NOTCH2 is a suppressor of transforming growth factor (TGF)-β1 signaling, which is correlated to the maintenance of chronic inflammation and involved in modulating various pathological processes, including NAFLD [22]. This evidence concerns the gene NOTCH2 and metabolic dysfunction-associated steatotic liver disease.